Strategic Evidence & Value Communication Symposium
Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…
Certara2021年3月26日
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…
Certara2021年3月23日
Systematic literature review of cross-protective effect of HPV vaccines based on data from randomized clinical trials and real-world evidence
The extent of cross-protection provided by currently licensed bivalent and quadrivalent HPV vaccines versus direct…
Certara2021年3月18日
Simcyp Simulator Impacts 80+ Novel Drugs
250 Label claims using PBPK without the need for additional clinical studies “Clinical Studies and…
Certara2021年3月17日
Can Biosimulation Provide the Key to Unlocking the Neurodegenerative Disease Development Challenge?
By Professor Piet van der Graaf, Ph.D., and Hugo Geerts, Ph.D. Neurodegenerative diseases (NDs) affect…
Certara2021年3月10日
PK Submit CDISC Technology
PK Submit automates the time consuming, error-prone and complex task of creating CDISC domains as…
Certara2021年3月10日
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…
Certara2021年3月10日
R Speaks NLME (RsNLME)
Download the brochure to learn more about RsNLME’s features and benefits.
Certara2021年3月9日
